According to Dermapharm's latest financial reports the company's current EPS (TTM) is $3.19. In 2022 the company made an earnings per share (EPS) of $3.51 a decrease over its 2021 EPS that were of $6.07.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $3.25 | -7.37% |
2022 | $3.51 | -42.21% |
2021 | $6.07 | 144.18% |
2020 | $2.49 | 14.58% |
2019 | $2.17 | -3.15% |
2018 | $2.24 | -34.2% |
2017 | $3.40 |